What's New

Volunteer Update: Thank You to Our Volunteers!

To all those who dedicate their time and energy with AFTD to making a difference within the FTD community, we thank you! Every hour you invest and every task you…

Read More about Volunteer Update: Thank You to Our Volunteers!

Advancing Hope: AFTD Attends 2025 American Academy of Neurology (AAN) Meeting

Staff from AFTD and the FTD Disorders Registry attended the American Academy of Neurology’s Annual Meeting earlier this month in San Diego. This meeting typically attracts around 14,000 international attendees,…

Read More about Advancing Hope: AFTD Attends 2025 American Academy of Neurology (AAN) Meeting

AFTD Webinar: How to Find a Genetic Counselor

FTD has a stronger genetic risk than other dementias. While not all FTD is inherited, understanding whether the FTD in your family is genetic is crucial: it can confirm the…

Read More about AFTD Webinar: How to Find a Genetic Counselor

PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial

A phase 2 clinical trial evaluating a telehealth therapy intervention for primary progressive aphasia (PPA) published positive results, with participants showing improvement in PPA’s communication-related symptoms. The Communication Bridge 2…

Read More about PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial

AFTD Ambassador Spencer Cline Delivers Moving Keynote Address at Hope Rising 

“We are not a product of what has happened to us. We have the power of choice.” ― Stephen Covey, Author  “When your biggest fear is FTD, it makes you…

Read More about AFTD Ambassador Spencer Cline Delivers Moving Keynote Address at Hope Rising 

Advocacy Update: Amplifying AFTD’s Advocacy

AFTD is deeply concerned about staff cuts and funding disruptions at the U.S. Department of Health and Human Services (HHS), and the potential impact they will have on dementia-focused research…

Read More about Advocacy Update: Amplifying AFTD’s Advocacy

Study Evaluates the Efficacy of Nasally Administered Hormone for Apathy in FTD

A study published in the journal The Lancet Neurology evaluates the efficacy of the hormone oxytocin as a treatment for apathy, a common symptom of FTD disorders. Co-authors of the…

Read More about Study Evaluates the Efficacy of Nasally Administered Hormone for Apathy in FTD

ABC News Honors AFTD Ambassador Spencer Cline as “Person of the Week”

Raising FTD awareness was a key goal of Spencer Cline’s as he set out from Oregon on a bike ride across America last summer. He got a well-deserved tailwind in…

Read More about ABC News Honors AFTD Ambassador Spencer Cline as “Person of the Week”

Speech Therapy CE Course Features AFTD Ambassador Dawn Ducca

AFTD Ambassador Dawn Ducca is interviewed in a new hourlong continuing education episode for speech language pathology (SLP) professionals on the platform Speech TherapyPD. The episode, “Understanding and Caring for…

Read More about Speech Therapy CE Course Features AFTD Ambassador Dawn Ducca

Hope Rising Benefit Raises Over $1.9 Million for AFTD’s Mission

Top row, L-R: Hope Rising MC Paula Zahn, Hope Rising Benefit Co-Chairs Joan Berlin and Anna Wintour, AFTD Ambassador Spencer Cline, Ariana DeBose, New York State Senator Michelle Hinchey

Read More about Hope Rising Benefit Raises Over $1.9 Million for AFTD’s Mission